Eli Lilly Says Zepbound Delivers Greater Weight Loss Than Higher-Dose Version of Novo's Wegovy

By Kelly CloonanEli Lilly says certain doses of its injectable GLP-1 drug Zepbound delivered greater weight loss than a higher-dose version of rival Novo Nordisk's Wegovy in a recent analysis.In an indirect treatment comparison, participants taking 10 milligram and 15 milligram doses of Zepbound lo…